Lead Plaintiff Deadline is December 21, 2015

NEW YORK, Oct. 29, 2015 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed in the United States District Court for the Southern District of Texas on behalf of all persons or entities that purchased the securities of Nobilis Health Corp. (“Nobilis”or the “Company”) (NYSE:HLTH) and (TSE:HLTH) between April 2, 2015 through October 8, 2015 (the “Class Period”), inclusive, on the New York Stock Exchange.

The Company’s shares are dually-listed in the United States and Canada. Shareholders who incurred losses on shares on purchased on either the New York Stock Exchange or Toronto Stock Exchange within the Class Period are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.

If you purchased the shares of Nobilis Health Corp. during the period April 2, 2015 through October 8, 2015, inclusive, you may, no later than December 21, 2015, request that the Court appoint you lead plaintiff of the proposed class.

The filed complaint alleges that throughout the Class Period, defendants made materially false and misleading statements and failed to disclose that: (i) Nobilis’s AccuraScope procedure, a purportedly minimally invasive spine surgery, lacked recognition from any university, medical body, or insurance company; (ii) the Company had overstated its 2014 revenues by as much as $36 million US; and (iii) consequently, the Company had misrepresented its 2014 revenue growth rate as 161%, when it was actually only 44%.

On October 9, 2015, Seeking Alpha published an article describing the AccuraScope procedure’s “questionable insurability, unsubstantiated success rates, [and] lack of recognition from” universities, medical bodies, and insurance companies. The article additionally noted significant accounting red flags at Nobilis and reported that Nobilis had overstated its 2014 revenues by as much as $36 million US. On this news, the price of Nobilis common stock fell $1.42 US per share, or 27% from its closing price of $5.24 US on October 8, 2015 to close at $3.82 US per share on October 9, 2015.

Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.  The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego.  The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.

If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein Adler Freeman & Herz LLP by telephone at (800) 575-0735, via e-mail at classmember@whafh.com, or visit our website at www.whafh.com.  All e-mail correspondence should make reference to the “Nobilis Investigation.”

Attorney Advertising. Prior results do not guarantee or predict a similar outcome.

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP 
Patrick Donovan, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: gstone@whafh.com, donovan@whafh.com or classmember@whafh.com
Tel: (800) 575-0735 or (212) 545-4774

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.